Initiator Pharma A/S: Financial statements 2018
CVR: 37663808
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Initiator Pharma A/S (CVR 37663808) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -11,437,000 and a net result of DKK -10,298,000 compared with DKK -8,582,000 the year before. Equity in the 2018 report amounted to DKK 16,570,000. The solvency ratio was 95.6%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -11,437,000
- Profit/Loss
- DKK -10,298,000
- Equity
- DKK 16,570,000
- Total Assets
- DKK 17,328,000
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -11.4M | -10.3M | 16.6M | 1 |
| 2017 | - | -8.2M | -8.6M | 6M | 2 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
Initiator Pharma A/S has published its annual report for 2017. Gross profit came to DKK -8,180,000, and the net result was DKK -8,582,000.
About Initiator Pharma A/S
Initiator Pharma A/S is a Danish company of the type Aktieselskab based in København N, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Claus Elsborg Olesen. The board consists of Gunnar Magnus Severus Modée Persson (chair), Annette Ingegerd Marie Colin, Claus Elsborg Olesen and Majken Christina Östberg Lloyd. The company is owned by Linc AB and Adrigo Asset Management. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK -14,828,000 and a net result of DKK -13,687,000 compared with DKK -12,932,000 the year before. Equity in the 2025 report amounted to DKK 29,546,000.